Results 11 to 20 of about 2,671,764 (310)

Real-World Evidence: A Primer

open access: yesPharmaceutical Medicine, 2023
Real-world evidence (RWE) is clinical evidence on a medical product’s safety and efficacy that is generated using real-world data (RWD) resulting from routine healthcare delivery.
A. Dang
semanticscholar   +3 more sources

ESMO Guidance for Reporting Oncology real-World evidence (GROW)

open access: yesAnnals of Oncology, 2023
Highlights • Real-world evidence in oncology is evolving rapidly with many particularities.• This guidance provides key recommendations for reporting real-world evidence studies in oncology.• Recommendations are based on a review of current evidence and ...
Rodrigo Dienstmann   +2 more
exaly   +3 more sources

The relevance of the real-world evidence in research, clinical, and regulatory decision making

open access: yesFrontiers in Public Health
The scientific method has been established as the optimal approach for systematically gathering and interpreting data on various human phenomena, mainly through the adoption of strict experimental methods, such as controlled randomized trials, which is ...
, Fregni Felipe
exaly   +2 more sources

A Review of the Importance and Relevance of Real-World Data and Real-World Evidence

open access: yesMedical Science Monitor
Real-world data are routinely collected data associated with patient health status or delivery of health care from sources including patient registries, electronic health records (EHRs), medical claims data, or digital health technologies.
D. Parums
semanticscholar   +3 more sources

A causal roadmap for generating high-quality real-world evidence [PDF]

open access: yesJournal of Clinical and Translational Science, 2023
Increasing emphasis on the use of real-world evidence (RWE) to support clinical policy and regulatory decision-making has led to a proliferation of guidance, advice, and frameworks from regulatory agencies, academia, professional societies, and industry.
L. Dang   +25 more
semanticscholar   +1 more source

Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

open access: yesRespiratory Research, 2023
Background Triple therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who remain symptomatic despite dual therapy. The optimal timing of triple therapy following an exacerbation of COPD is unknown. The outcomes of prompt
Afisi S. Ismaila   +10 more
doaj   +1 more source

Real-World Evidence for Equality

open access: yesHealth Equity, 2021
As stakeholders in the transformative medical research ecosystem, real-world evidence researchers must conduct observational research with an awareness of racism. Advancements in understanding of the impact of racism on health outcomes, the abundance of health care data, and innovations in health information technology provide tools that create ...
C. Erwin Johnson, Yohance Omar Whiteside
openaire   +3 more sources

Real-World Evidence: A Primer

open access: yesJournal of Orthopaedic Trauma, 2021
Summary: The insights that real-world data (RWD) can provide, beyond what can be learned within the traditional clinical trial setting, have gained enormous traction in recent years. RWD, which are increasingly available and accessible, can further our understanding of disease, disease progression, and safety and effectiveness of treatments ...
Robert, Zura   +4 more
openaire   +3 more sources

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

open access: yesBMJ Open Respiratory Research, 2022
Introduction Treatment pathways of patients with chronic obstructive pulmonary disease (COPD) receiving single-device dual therapies in England remain unclear.
Victoria Banks   +8 more
doaj   +1 more source

Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes

open access: yesCurrent Medical Research and Opinion, 2023
Objective To update on and describe the role of Disease Specific Programmes (DSPs), a multi-perspective real-world data (RWD) source, in the context of the evolution of the value and acceptance of real-world evidence (RWE) in clinical, regulatory and ...
Peter Anderson   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy